Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

There is a growing body of research being published regarding salivary diagnostic testing and its application for the early detection of disease. Please check this web site frequently for the latest published research regarding salivary diagnostic testing. Simply click the individual titles below to download the complete publication.



CCEDV36N5_Cover_5th.inddVolume 36, Issue 5
Published by AEGIS Communications

Evaluation of Salivary Transcriptome Markers for the Early Detection of Oral Squamous Cell Cancer in a Prospective Blinded Trial

Jack L. Martin, MD; Neil Gottehrer, DDS; Harvey Zalesin, DDS; Paul T. Hoff, MD; Michael Shaw, PhD; James H.W. Clarkson, MD; Pam Haan, BSN; Mark Vartanian; Terry McLeod, BSN; and Stephen M. Swanick


Prevalidation of Salivary Biomarkers for Oral Cancer Detection

By David Elashoff, Hui Zhou, Jean Reiss, Jianghua Wang, Hua Xiao, Bradley Henson, Shen Hu,Martha Arellano, Uttam Sinha, Anh Le, Diana Messadi, Marilene Wang, Vishad Nabili, Mark Lingen, Darly Morris, Timothy Randolph, Ziding Feng, David Akin, Dragana A. Kastratovic, David Chia, Elliot Abemayor, and David T.W. Wong\